IQVIA’s Post

Discover how IQVIA’s Lifecycle Management (LCM) Services created a 30% cost-saving for a pharma customer.

Check out this newly published report featuring a Clinical Trial Readiness Analysis developed by the IQVIA Institute that allows for ranking of countries by trial type, and surfaces near- and long-term opportunities for investment and improvement in country utilization.

IQVIA Transparency Reporting is helping LEO Pharma, a global company dedicated to advancing the standard of care for the benefit of people with skin conditions, keep up with consistently changing global transparency legislations, regulations, and codes, which is a major challenge for life sciences companies of all sizes. IQVIA’s Transparency Reporting makes reporting seamless with a user-friendly, intuitive process, and best-in-class SaaS technology, combined with continuous legal monitoring expertise that provides regulatory updates to stay compliant. “LEO Pharma utilizes IQVIA's Transparency Reporting solution to streamline our global transparency reporting process, significantly reducing the time and resources previously devoted to the reporting process. The advanced analytics and user-friendly dashboards have empowered us to focus more on strategic growth while ensuring compliance with changing global regulations.” said the Head of HCP Compliance at LEO Pharma. LEO Pharma uses IQVIA’s Transparency Reporting solution to meet global transparency requirements across 22 countries. With this robust SaaS solution, the company can streamline their data integration from all sources, remediate and manage spend with in depth reporting tools, and utilize robust analytics to drive greater compliance insights, all on a single platform. For more information on IQVIA Transparency Reporting, visit https://bit.ly/4bLMCY1.

Are you planning for evidence generation and dissemination early enough in your product’s lifecycle? Partner with IQVIA Medical Affairs to advance healthcare decision-making that improves patient outcomes. https://bit.ly/3zEQj4z #medaffairs

We are excited to announce that Everest Group has recognized IQVIA as a Leader in Life Sciences Regulatory and Medical Affairs Operations. #IQVIANewsroom “IQVIA is honored to be recognized for its role in enabling our medical affairs and regulatory customers to close the gap between medical knowledge and medical practice to improve patients’ lives” said Rob Kotchie, president, Real World Solutions, IQVIA. Read the full press release here: https://bit.ly/3WhxpcM

In this new article published by Applied Clinical Trials Magazine, IQVIA’s Matt Reaney, Rachel Bruce, Kim Kelly, and Lindsay Hughes propose a 3-part framework for a more comprehensive conceptual model of patient experience that can provide a more rounded understanding of patient experiences in clinical trials and beyond. https://bit.ly/3y4nZYO

Let your true potential shine during the interview process. See our list of tips for before, during and after your IQVIA interview: https://bit.ly/3zEdc8p #GetHired #WeAreIQVIA

This article by IQVIA’s Mackenzie Herzog and fellow sports medicine experts, Andrew Kuhn, M.D., Nate Weir, MS, LAT, ATC, and Bob Anderson, correlates EMR data on ankle injuries in #NFL athletes with advanced imaging findings to understand how diagnosis impacts time to return to full participation. Learn how an evidence hub of linked and integrated health and statistical data sources can provide a foundation for decision-making and inform strategies for injury management. https://bit.ly/4cWg2nk

Our five-step #onboarding experience not only sets new employees up to do extraordinary things for our customers and partners, but helps them feel inspired, connected and enabled to do great things here. Learn more about our onboarding program: https://bit.ly/3xDlzAw #WeAreIQVIA

GVHD after HSCT is associated with poor HRQoL and functional status. This analysis, co-authored by IQVIA’s James Turnbull, assessed physical, cognitive, and work disability, and described factors predictive of disability in patients with chronic GVHD. The results highlight a need for improved social support for these patients. https://bit.ly/3Lj37jy